HighGravityDataHumana — Oct 30, 2024 release
Fiscal 2024 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000049071-24-000051
Showing in the filing
EPS, Adjusted basis
“at least $16.00”
Period
FY2024
Measure
Company-defined measure
Source
Prose
All guidance in this release · 28
EPS, GAAP basis for FY2024
“at least $12.89”
Diluted earnings per share (Adjusted non-GAAP) for FY2024
“at least $16.00”
EPS, Adjusted basis for FY2024
“at least $16.00”
Individual Medicare Advantage annual members… for FY2024
“approximately 265,000, or approximately 5 percent”
Diluted earnings per common share (GAAP) for FY2024
“at least $12.89”
Total Revenues: Consolidated for FY2024
“no change”
Change in year-end medical membership from p… for FY2024
“no change”
Total Revenues, Consolidated, GAAP for FY2024
“approximately $116 billion”
Total Revenues: CenterWell segment for FY2024
“no change”
Benefit Ratio: Insurance segment for FY2024
“no change”
Segment Results: Insurance segment income fr… for FY2024
“no change”
Total Revenues, Insurance segment, GAAP for FY2024
“approximately $112 billion”
Total Revenues, CenterWell segment, GAAP for FY2024
“approximately $19 billion”
Change in year-end medical membership from p… for FY2024
“Growth of approximately 265,000”
Change in year-end medical membership from p… for FY2024
“Growth of approximately 35,000”
Change in year-end medical membership, Medic… for FY2024
“Decline of approximately 600,000”
Change in year-end medical membership from p… for FY2024
“Growth of approximately 200,000”
Benefit Ratio, Insurance segment, GAAP for FY2024
“approximately 90%”
Operating Cost Ratio, Consolidated, GAAP for FY2024
“approximately 11.4%”
Operating Cost Ratio: Consolidated for FY2024
“no change”
Insurance segment income from operations, GAAP for FY2024
“approximately $1.1 billion”
Insurance segment income from operations, No… for FY2024
“approximately $1.2 billion”
CenterWell segment income from operations, N… for FY2024
“approximately $1.4 billion”
Effective Tax Rate, GAAP for FY2024
“approximately 25.2%”
Effective Tax Rate, Non-GAAP for FY2024
“approximately 25.0%”
Weighted Avg. Share Count for Diluted EPS for FY2024
“approximately 121 million”
Cash flows from operations, GAAP for FY2024
“approximately $2.75 billion”
Capital expenditures, GAAP for FY2024
“approximately $600 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
Box 1438 Louisville, KY 40202 http://www.humana.com FOR MORE INFORMATION CONTACT: Lisa Stoner Humana Investor Relations (502) 580-2652 e-mail: LStamper@humana.com Mark Taylor Humana Corporate Communications (317) 753-0345 e-mail: MTaylor108@humana.com Humana Reports Third Quarter 2024 Financial Results; Updates Full Year Adjusted 2024 Financial Guidance • Reports 3Q24 earnings per share (EPS) of $3.98 on a GAAP basis, Adjusted EPS of $4.16; reports YTD 2024 EPS of $15.72 on a GAAP basis, $18.35 on an Adjusted basis • Updates FY 2024 EPS guidance to 'at least $12.89' on a GAAP basis, 'at least $16.00' on an Adjusted basis; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent • Raises 2024 individual Medicare Advantage annual membership growth by 40,000 to now anticipate annual growth of approximately 265,000, or approximately 5 percent • Publishes prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 9:00 a.m. ET question and answer session to discuss its financial results for the quarter and expectations for future earnings LOUISVILLE, KY (October 30, 2024) – Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2024 (3Q24) versus the quarter ended September 30, 2023 (3Q23) and for the nine months ended September 30, 2024 (YTD 2024) versus the nine months ended September 30, 2023 (YTD 2023) as noted in the tables below. 1 Consolidated income before income taxes and equity in net earnings (pretax results) In millions 3Q24 (a) 3Q23 (a) YTD 2024 (a) YTD 2023 (a) Generally Accepted Accounting Principles (GAAP) $651 $1,098 $2,583 $3,974 Amortization associated with identifiable intangibles 15 17 46 51 Put/call valuation
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.